Nymox Pharmaceutical Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
295.50
632.30
374.50
2,018.00
851.00
7,946
Total Accounts Receivable
581.00
675.20
278.60
9.00
87.00
14
Inventories
39.70
88.30
37.60
3.00
15.00
41
Other Current Assets
37.70
-
0.70
8.00
8.00
25
Total Current Assets
953.90
1,395.80
691.40
2,038.00
961.00
8,026
Net Property, Plant & Equipment
12.50
9.40
3.40
2.00
1.00
33
Total Investments and Advances
-
17.40
-
-
-
-
Long-Term Note Receivable
-
-
-
-
718.00
868
Other Assets
-
-
17.40
17.00
17.00
17
Total Assets
966.40
1,422.60
712.20
2,057.00
1,697.00
8,944
Accounts Payable
1,383.00
1,484.30
1,840.20
1,142.00
2,017.00
Other Current Liabilities
2,733.20
3,000.30
410.40
226.00
213.00
Total Current Liabilities
4,116.20
4,484.70
2,250.60
1,368.00
2,230.00
Long-Term Debt
400.00
1,307.80
1,214.70
931.00
-
Other Liabilities
2,508.50
-
-
-
-
Total Liabilities
7,024.80
5,792.40
3,465.20
2,299.00
2,230.00
Common Equity (Total)
6,458.40
4,769.90
3,153.00
242.00
533.00
Total Shareholders' Equity
6,458.40
4,769.90
3,153.00
242.00
533.00
Total Equity
6,058.40
4,369.90
2,753.00
242.00
533.00
Liabilities & Shareholders' Equity
966.40
1,422.60
712.20
2,057.00
1,697.00
Accumulated Minority Interest
400.00
400.00
400.00
-
-
About Nymox Pharmaceutical
View Profile
